TNYA – tenaya therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Tenaya Therapeutics (NASDAQ:TNYA) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $9.00 price target on the stock.
Tenaya Therapeutics, Inc. (TNYA) Shareholder/Analyst Call Transcript [Seeking Alpha]
Tenaya Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy [Yahoo! Finance]
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy
Form 4 Tenaya Therapeutics, For: Nov 17 Filed by: Higa Tomohiro
Form 4 Tenaya Therapeutics, For: Nov 17 Filed by: Tingley Whittemore
Form 4 Tenaya Therapeutics, For: Nov 17 Filed by: Ali Faraz
Form 10-Q Tenaya Therapeutics, For: Sep 30
Form 8-K Tenaya Therapeutics, For: Nov 10
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.